熱門資訊> 正文

Edwards Lifesciences推出5亿美元加速股票回购

2025-08-20 04:57

Edwards Lifesciences (NYSE:EW) said on Tuesday that it has signed a $500 million accelerated share repurchase agreement, bringing total buybacks this year to over $800 million.
As per the repurchase agreement, Edwards will receive an initial delivery of about 5 million shares and the remainder at the maturity of the agreement.
Post this offering, co would have around $600 million left under its board-approved repurchase program.
EW +1.53% after hours to $80.14.
Source: Press Release

More on Edwards Lifesciences

Edwards Lifesciences: Gradually Winning My Investment Heart
Edwards Lifesciences Corporation (EW) Q2 2025 Earnings Call Transcript
Edwards Lifesciences: With A Heart Beating Strong And Steady
FTC sues to block Edwards Lifesciences purchase of JenaValve
Edwards Lifesciences raises 2025 sales growth outlook to 9-10% amid robust TAVR and TMTT momentum

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。